NCT00006258View on ClinicalTrials.gov

Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1997

Study Completion Date

January 31, 2005

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

filgrastim

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

etoposide

DRUG

methotrexate

DRUG

vincristine sulfate

PROCEDURE

adjuvant therapy

RADIATION

radiation therapy

Trial Locations (3)

90027-0700

Children's Hospital Los Angeles, Los Angeles

17822-1320

Geisinger Medical Center, Danville

T2N 4N2

Tom Baker Cancer Centre - Calgary, Calgary

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Hospital Los Angeles

OTHER

NCT00006258 - Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma | Biotech Hunter | Biotech Hunter